Literature DB >> 12937133

Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.

Masashi Nakayama1, Christina J Bennett, Jessica L Hicks, Jonathan I Epstein, Elizabeth A Platz, William G Nelson, Angelo M De Marzo.   

Abstract

Somatic inactivation of the glutathione S-transferase-pi gene (GSTP1) via CpG island hypermethylation occurs early during prostate carcinogenesis, present in approximately 70% of high-grade prostatic intraepithelial neoplasia (high-grade PIN) lesions and more than 90% of adenocarcinomas. Recently, there has been a resurgence of the concept that foci of prostatic atrophy (referred to as proliferative inflammatory atrophy or PIA) may be precursor lesions for the development of prostate cancer and/or high-grade PIN. Many of the cells within PIA lesions contain elevated levels of GSTP1, glutathione S-transferase-alpha (GSTA1), and cyclooxygenase-II proteins, suggesting a stress response. Because not all PIA cells are positive for GSTP1 protein, we hypothesized that some of the cells within these regions acquire GSTP1 CpG island hypermethylation, increasing the chance of progression to high-grade PIN and/or adenocarcinoma. Separate regions (n =199) from 27 formalin-fixed paraffin-embedded prostates were microdissected by laser-capture microdissection (Arcturus PixCell II). These regions included normal epithelium (n = 48), hyperplasticepithelium from benign prostatic hyperplasia nodules (n = 22), PIA (n = 64), high-grade PIN (n = 32), and adenocarcinoma (n = 33). Genomic DNA was isolated and assessed for GSTP1 CpG island hypermethylation by methylation-specific polymerase chain reaction. GSTP1 CpG island hypermethylation was not detected in normal epithelium (0 of 48) or in hyperplastic epithelium (0 of 22), but was found in 4 of 64 (6.3%) PIA lesions. The difference in the frequency of GSTP1 CpG island hypermethylation between normal or hyperplastic epithelium and PIA was statistically significant (P = 0.049). Similar to studies using nonmicrodissected cases, hypermethylation was found in 22 of 32 (68.8%) high-grade PIN lesions and in 30 of 33 (90.9%) adenocarcinoma lesions. Unlike normal or hyperplastic epithelium, GSTP1 CpG island hypermethylation can be detected in some PIA lesions. These data support the hypothesis that atrophic epithelium in a subset of PIA lesions may lead to high-grade PIN and/or adenocarcinoma. Because these atrophic lesions are so prevalent and extensive, even though only a small subset contains this somatic DNA alteration, the clinical impact may be substantial.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937133      PMCID: PMC1868250          DOI: 10.1016/s0002-9440(10)63452-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Atrophy and hyperplasia in the prostate proper.

Authors:  L M FRANKS
Journal:  J Pathol Bacteriol       Date:  1954-10

2.  Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

Authors:  S Zha; W R Gage; J Sauvageot; E A Saria; M J Putzi; C M Ewing; D A Faith; W G Nelson; A M De Marzo; W B Isaacs
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

3.  Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

Authors:  C Jerónimo; H Usadel; R Henrique; J Oliveira; C Lopes; W G Nelson; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

Review 4.  New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.

Authors:  A M De Marzo; D S Coffey; W G Nelson
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

5.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.

Authors:  G J Nuovo; T W Plaia; S A Belinsky; S B Baylin; J G Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.

Authors:  X Lin; M Tascilar; W H Lee; W J Vles; B H Lee; R Veeraswamy; K Asgari; D Freije; B van Rees; W R Gage; G S Bova; W B Isaacs; J D Brooks; T L DeWeese; A M De Marzo; W G Nelson
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

7.  8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer.

Authors:  J A Macoska; T M Trybus; K J Wojno
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

8.  Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.

Authors:  C I Suh; T Shanafelt; D J May; K R Shroyer; J B Bobak; E D Crawford; G J Miller; N Markham; L M Glode
Journal:  Mol Cell Probes       Date:  2000-08       Impact factor: 2.365

9.  The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods.

Authors:  T Shirai; M Sano; S Tamano; S Takahashi; M Hirose; M Futakuchi; R Hasegawa; K Imaida; K Matsumoto; K Wakabayashi; T Sugimura; N Ito
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

10.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Authors:  R Shah; N R Mucci; A Amin; J A Macoska; M A Rubin
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

View more
  93 in total

Review 1.  In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

2.  Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma.

Authors:  Queeny K Y Chan; Ui-Soon Khoo; Kelvin Y K Chan; Hextan Y S Ngan; Shan-Shan Li; Pui-Man Chiu; Li-Shan Man; Philip P C Ip; Wei-Cheng Xue; Annie N Y Cheung
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

3.  [Epigenetic processes in prostate carcinoma. Study of cellular information carriers beyond DNA sequence].

Authors:  P J Bastian; J Ellinger; S C Müller; A von Rücker
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

4.  Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues.

Authors:  Dimo Dietrich; Ralf Lesche; Reimo Tetzner; Manuel Krispin; Jörn Dietrich; Wolfgang Haedicke; Matthias Schuster; Glen Kristiansen
Journal:  J Histochem Cytochem       Date:  2009-01-19       Impact factor: 2.479

Review 5.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

Review 6.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 7.  Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.

Authors:  Srinivasan Yegnasubramanian; Angelo M De Marzo; William G Nelson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

8.  Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy.

Authors:  M Karaivanov; K Todorova; A Kuzmanov; S Hayrabedyan
Journal:  J Mol Histol       Date:  2006-12-15       Impact factor: 2.611

9.  DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.

Authors:  D Pellacani; D Kestoras; A P Droop; F M Frame; P A Berry; M G Lawrence; M J Stower; M S Simms; V M Mann; A T Collins; G P Risbridger; N J Maitland
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

Review 10.  Urinary biomarkers for prostate cancer: a review.

Authors:  Daphne Hessels; Jack A Schalken
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.